Loading the map…
Private limited company registered in Wrexham, classed under “Physical well-being activities”.
Headline figures
FY to Jan 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Current assets | ||
| Creditors due within a year | ||
| Net current assets | ||
| Net assets | ||
| Ratios | ||
| Current ratioCurrent assets for every £1 owed within a year | ||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||
4 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does The Wellness Director do?
Private limited company registered in Wrexham, classed under “Physical well-being activities”.
›How much turnover does The Wellness Director make?
Answered in the full report
›Is The Wellness Director profitable?
The Wellness Director's profit isn't public: small companies may file without a profit and loss account.
›How many people work at The Wellness Director?
Answered in the full report
›Where is The Wellness Director based?
Its registered office is 45 Smithy Lane, Wrexham, Clwyd, LL12 8JN, in Wrexham, Clwyd.
›When was The Wellness Director founded?
The Wellness Director Ltd was incorporated on 30 January 2023.
›Is The Wellness Director still trading?
The register lists The Wellness Director Ltd as active.